DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xeloda (Capecitabine) - Vomiting - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Vomiting (177)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Xeloda (Capecitabine) where reactions include vomiting. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 177   Next >>

Possible Xeloda side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: male, weighing 101.7 kg (223.7 pounds)

Reactions: Death, Fatigue, Vomiting

Adverse event resulted in: death

Drug(s) suspected as cause:
Xeloda

Xeloda
    Administration route: Oral
    Indication: Bile Duct Cancer
    Start date: 2012-02-06

Other drugs received by patient: Prochlorperazine; Prochlorperazine



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Mexico on 2012-08-27

Patient: female, weighing 43.0 kg (94.6 pounds)

Reactions: Thrombosis, Vomiting, Monoplegia, Nausea, Diarrhoea, Oedema Peripheral, Headache

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient: male, weighing 89.9 kg (197.8 pounds)

Reactions: Vomiting, Dyspnoea, Nausea, Dehydration, Pneumomediastinum, Pneumothorax, Odynophagia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-15

Avastin
    Dosage: last dose recieved on 14 feb 2012
    End date: 2012-02-14

Herceptin
    Dosage: last dose recieved on 14 feb 2012.
    End date: 2012-02-14

Herceptin
    Dosage: last dose recieved on 14 feb 2012.
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-10
    End date: 2011-11-15

Oxaliplatin
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-15

Oxaliplatin
    End date: 2012-02-14

Xeloda
    End date: 2012-02-26

Xeloda
    Indication: Oesophageal Cancer Metastatic
    Start date: 2011-05-17
    End date: 2011-11-29

Other drugs received by patient: Actos; Lorazepam; DTO; Prilosec; Ritalin; Toprol-XL; Potassium Chloride; Lomotil; Dexamethasone; Compazine; Prednisone TAB; Citalopram Hydrobromide; Morphine Sulfate; Lisinopril; Metoprolol Tartrate; Dicyclomine; Methylphenidate; Zofran; Oxycodone HCL; Decadron Phosphate; Bentyl; Emend



Possible Xeloda side effects in female

Reported by a physician from Switzerland on 2012-08-22

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Abdominal Pain, Vomiting, Anaemia, Lymphopenia, Pyrexia, Diarrhoea, Small Intestinal Perforation, Sepsis, Hypoalbuminaemia, Neutropenia, Enterocolitis, Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Herceptin



Possible Xeloda side effects in

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-08-21

Patient:

Reactions: Proctitis, Vomiting, Diarrhoea, Nausea, Sepsis, Faecal Incontinence, Pulmonary Embolism, Cardiotoxicity, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Oxaliplatin
    Dosage: days 1, 8, and 15
    Indication: Rectal Cancer

Xeloda
    Dosage: monday to friday
    Indication: Rectal Cancer



Possible Xeloda side effects in 79 year old male

Reported by a consumer/non-health professional from China on 2012-08-20

Patient: 79 year old male

Reactions: Productive Cough, Aphasia, Bronchial Carcinoma, Rash Pruritic, Poor Quality Sleep, Death, Incontinence, Oedema Peripheral, Blood Creatinine Increased, Epistaxis, Decreased Appetite, Emphysema, Dyspnoea, Blood Urea Increased, Stomatitis, Vomiting, Nausea, Rhinorrhoea, Diarrhoea, Cerebral Infarction, Depressed Level of Consciousness, Metastases To Bone, Asthenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Rectal Cancer Metastatic

Tarceva
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2012-06-01
    End date: 2012-06-09

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    End date: 2012-02-23



Possible Xeloda side effects in 60 year old female

Reported by a physician from Canada on 2012-08-20

Patient: 60 year old female

Reactions: Vomiting, Nausea, Diarrhoea, Neoplasm Malignant, Dehydration, Disease Progression, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Tykerb
    Administration route: Oral

Tykerb
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Xeloda
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Hydromorphone Hydrochloride; Retinol; Prevacid; Micardis; Verapamil HCL; Celebrex; Colace; Vitamin D; Antihypertensive Medications; Actonel; Senokot



Possible Xeloda side effects in 79 year old male

Reported by a consumer/non-health professional from China on 2012-08-20

Patient: 79 year old male

Reactions: Asthma, Productive Cough, Urinary Incontinence, Bronchial Carcinoma, Aphasia, Rash Pruritic, Off Label Use, Poor Quality Sleep, Death, Oedema Peripheral, Blood Creatinine Increased, Epistaxis, Decreased Appetite, Emphysema, Stomatitis, Vomiting, Pneumonia, Dyspnoea, Blood Urea Increased, Nausea, Rhinorrhoea, Rash, Diarrhoea, Cerebral Infarction, Depressed Level of Consciousness, Metastases To Bone, Asthenia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: unk
    Indication: Rectal Cancer Metastatic

Tarceva
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2012-06-01
    End date: 2012-06-09

Xeloda
    Dosage: 1.5 df, bid for 2 weeks followed by 7 day rest period
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    End date: 2012-02-23



Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-08-16

Patient: female, weighing 44.0 kg (96.8 pounds)

Reactions: Vomiting, Dermatitis, Cerebral Vasoconstriction, Cerebral Infarction, Cerebrovascular Spasm

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Rectal Cancer Recurrent
    Start date: 2012-05-21
    End date: 2012-05-21

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer Recurrent
    Start date: 2012-05-21
    End date: 2012-05-23

Other drugs received by patient: Oxycontin; Celebrex; Oxaliplatin; Hochuekkito



Possible Xeloda side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-14

Patient: male, weighing 55.4 kg (121.9 pounds)

Reactions: Back Pain, Vomiting, Nausea, Musculoskeletal Pain, Abasia, Pain, Ill-Defined Disorder, Malaise, Fatigue, Ageusia, Diarrhoea, Gait Disturbance, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda
    Administration route: Oral
    Start date: 2012-05-24
    End date: 2012-05-31

Xeloda
    Administration route: Oral
    Indication: Colon Cancer
    Start date: 2012-05-07
    End date: 2012-05-24

Xeloda
    Administration route: Oral
    Start date: 2012-06-02
    End date: 2012-07-05

Other drugs received by patient: Oxaliplatin



Possible Xeloda side effects in female

Reported by a pharmacist from United States on 2012-08-09

Patient: female

Reactions: Vomiting, Dyspnoea, Renal Failure, Nausea, Drug Intolerance, Tremor

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Compazine; Lovaza; Cardizem; Hydrochlorothiazide; Coq10; Lotemax; Oxycodone HCL; Levothyroxine Sodium; Fentanyl; Metformin; Vitamin D



Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-08-08

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Incontinence, Vomiting, Disseminated Intravascular Coagulation, Acute Hepatic Failure, Altered State of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Meropenem
    Dosage: dosage is uncertain.
    Indication: Infection Prophylaxis
    Start date: 2011-10-14
    End date: 2011-10-18

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer
    Start date: 2011-08-29
    End date: 2011-09-11

Xeloda
    Administration route: Oral
    Start date: 2011-09-26
    End date: 2011-10-09

Other drugs received by patient: Ganaton; Aloxi; Famotidine; Oxaliplatin; Pydoxal; Dexamethasone Sodium Phosphate



Possible Xeloda side effects in 78 year old male

Reported by a consumer/non-health professional from China on 2012-08-07

Patient: 78 year old male

Reactions: Productive Cough, Asthma, Aphasia, Bronchial Carcinoma, Rash Pruritic, Death, Off Label Use, Incontinence, Oedema Peripheral, Blood Creatinine Increased, Epistaxis, Decreased Appetite, Stomatitis, Dyspnoea, Vomiting, Blood Urea Increased, Nausea, Diarrhoea, Insomnia, Depressed Level of Consciousness, Metastases To Bone, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: unk
    Indication: Rectal Cancer Metastatic

Tarceva
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2012-06-01
    End date: 2012-06-09

Xeloda
    Dosage: 1.5 df, bid for 2 weeks followed by 7 day rest period
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    End date: 2012-02-23



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient: female

Reactions: Death, Vomiting, Oedema Peripheral, Insomnia, Asthenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in 78 year old male

Reported by a consumer/non-health professional from China on 2012-08-06

Patient: 78 year old male

Reactions: Productive Cough, Asthma, Aphasia, Bronchial Carcinoma, Rash Pruritic, Death, Incontinence, Oedema Peripheral, Blood Creatinine Increased, Decreased Appetite, Epistaxis, Vomiting, Stomatitis, Dyspnoea, Blood Urea Increased, Nausea, Diarrhoea, Depressed Level of Consciousness, Metastases To Bone, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Rectal Cancer Metastatic

Tarceva
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2012-06-01
    End date: 2012-06-09

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    End date: 2012-02-23



Possible Xeloda side effects in female

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-06

Patient: female

Reactions: Dyspnoea, Vomiting, Nausea, Headache, Pericardial Effusion, Dysgeusia, Diarrhoea, Chest Pain, Pulmonary Thrombosis, Decreased Appetite

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Tykerb
    Indication: Breast Cancer
    Start date: 2012-01-23
    End date: 2012-07-01

Xeloda
    Indication: Breast Cancer
    Start date: 2012-01-23
    End date: 2012-07-01



Possible Xeloda side effects in

Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-08-06

Patient:

Reactions: Vomiting, Anaemia, Pulmonary Embolism, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Peripheral Sensory Neuropathy, Mucosal Inflammation, Diarrhoea, Proteinuria, Neutropenia, Leukopenia

Drug(s) suspected as cause:
Avastin
    Dosage: fluorouracil based regimen
    Indication: Colorectal Cancer Metastatic

Avastin
    Dosage: capecitabine-based regimen

Fluorouracil
    Dosage: on day 1

Fluorouracil
    Indication: Colorectal Cancer Metastatic

Irinotecan Hydrochloride
    Dosage: dose: 150/180 mg/m2 on day 1
    Indication: Colorectal Cancer Metastatic

Leucovorin Calcium
    Dosage: on day 1
    Indication: Colorectal Cancer Metastatic

Oxaliplatin
    Dosage: on day 1
    Indication: Colorectal Cancer Metastatic

Xeloda
    Indication: Colorectal Cancer Metastatic



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-08-03

Patient: female, weighing 92.5 kg (203.5 pounds)

Reactions: Vomiting, Nausea, General Physical Health Deterioration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer
    Start date: 2011-12-22
    End date: 2012-06-21

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-12-22
    End date: 2012-06-21

Other drugs received by patient: Xgeva



Possible Xeloda side effects in female

Reported by a physician from Japan on 2012-07-30

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Vomiting, Incontinence, Disseminated Intravascular Coagulation, Platelet Count Decreased, Acute Hepatic Failure, Neutropenia, Altered State of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Meropenem
    Dosage: dosage is uncertain.
    Indication: Infection Prophylaxis
    Start date: 2011-10-14
    End date: 2011-10-18

Xeloda
    Administration route: Oral
    Indication: Rectal Cancer
    Start date: 2011-08-29
    End date: 2011-09-11

Xeloda
    Administration route: Oral
    Start date: 2011-09-26
    End date: 2011-10-09

Other drugs received by patient: Aloxi; Dexamethasone Sodium Phosphate; Ganaton; Oxaliplatin; Famotidine; Pydoxal



Possible Xeloda side effects in 51 year old female

Reported by a physician from Canada on 2012-07-30

Patient: 51 year old female

Reactions: Vomiting, Tongue Discolouration, Diarrhoea, Insomnia, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
Tykerb
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Xeloda
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Norvasc; Prochlorperazine; Decadron; Docusate Sodium; Lactulose; Pantoprazole Sodium; Metformin Hydrochloride; Tylenol with Codeine #3 (United States)



Possible Xeloda side effects in female

Reported by a physician from United States on 2012-07-26

Patient: female, weighing 65.8 kg (144.8 pounds)

Reactions: Pneumonia, Vomiting, Diarrhoea, Nausea, Urinary Tract Infection, Intestinal Obstruction, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda

Other drugs received by patient: Revlimid



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-07-24

Patient: female, weighing 92.5 kg (203.5 pounds)

Reactions: Vomiting, Nausea, General Physical Health Deterioration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer
    Start date: 2011-12-22
    End date: 2012-06-21

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2011-12-22
    End date: 2012-06-21

Other drugs received by patient: Xgeva



Possible Xeloda side effects in 48 year old male

Reported by a physician from Germany on 2012-07-20

Patient: 48 year old male

Reactions: Jaundice, Vomiting, Nausea, Neoplasm Malignant, Anaemia, Malignant Ascites, Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Oxaliplatin
    Indication: Pancreatic Carcinoma Metastatic
    Start date: 2009-07-01
    End date: 2010-04-01

Tarceva
    Indication: Pancreatic Carcinoma Metastatic
    Start date: 2007-02-27
    End date: 2009-07-15

Xeloda
    Indication: Pancreatic Carcinoma Metastatic
    Start date: 2009-07-01
    End date: 2010-04-01

Other drugs received by patient: Gemcitabine; Granocyte



Possible Xeloda side effects in female

Reported by a pharmacist from United States on 2012-07-20

Patient: female

Reactions: Abdominal Pain, Haematochezia, Vomiting, Stomatitis, Diarrhoea, Dehydration, Dizziness

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-20

Patient: female

Reactions: Confusional State, Vomiting, Adverse Drug Reaction, Constipation, Tremor

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-07-19

Patient: female

Reactions: Weight Decreased, Pulmonary Embolism, Pyrexia, Hyperhidrosis, Cardiac Disorder, Intestinal Perforation, Dyspepsia, Proteinuria, Epistaxis, Gingival Bleeding, Anaemia, Cardiomyopathy, Neutropenia, Hypersensitivity, Bone Pain, Pain, Chills, Skin Reaction, Abdominal Pain Upper, Polyneuropathy, Myalgia, Fatigue, Oedema, Dizziness, Myocardial Infarction, Nail Toxicity, Thrombocytopenia, Decreased Appetite, Vomiting, Dyspnoea, Nausea, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Cerebrovascular Accident, Dysgeusia, Mucosal Inflammation, Anxiety, Diarrhoea, Impaired Healing, Arthralgia, Hypertension, Asthenia, Leukopenia

Drug(s) suspected as cause:
Avastin
    Indication: Breast Cancer

Herceptin
    Indication: Breast Cancer

Xeloda
    Indication: Breast Cancer



Possible Xeloda side effects in female

Reported by a consumer/non-health professional from Canada on 2012-07-16

Patient: female

Reactions: Death, Breast Cancer Metastatic, Vomiting, Metastases To Liver, Metastases To Lung

Adverse event resulted in: death

Drug(s) suspected as cause:
Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2010-08-11
    End date: 2011-02-09

Xeloda
    Indication: Product Used FOR Unknown Indication



Possible Xeloda side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-16

Patient: male, weighing 63.6 kg (139.8 pounds)

Reactions: Vomiting, Nausea, Diarrhoea, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda



Possible Xeloda side effects in female

Reported by a physician from United States on 2012-07-11

Patient: female, weighing 31.8 kg (70.0 pounds)

Reactions: Weight Decreased, Abdominal Discomfort, Epistaxis, Product Counterfeit, Back Pain, Stomatitis, Wound Dehiscence, Pain in Extremity, Drug Intolerance, Toxicity To Various Agents, Paraesthesia, Eating Disorder, Tremor, Metastases To Spine, Skin Exfoliation, Abdominal Pain Upper, Death, Nephrolithiasis, Fatigue, Neuropathy Peripheral, Abdominal Distension, Decreased Appetite, Pain in JAW, White Blood Cell Count Decreased, Vomiting, Drug Hypersensitivity, Incorrect Dose Administered, Deformity, Skin Irritation, Ascites, Limb Deformity, Lung Disorder, Neoplasm Malignant, Flank Pain

Adverse event resulted in: death

Drug(s) suspected as cause:
Avastin

Avastin
    Start date: 2008-12-18
    End date: 2009-01-07

Avastin
    Indication: Colorectal Cancer Metastatic

Avastin
    Start date: 2007-08-01
    End date: 2007-09-01

Avastin
    Start date: 2009-01-28
    End date: 2009-05-13

Avastin

Avastin

Avastin
    Start date: 2009-05-27
    End date: 2009-09-01

Fluorouracil
    Dosage: bolus
    Start date: 2009-05-27
    End date: 2009-09-01

Fluorouracil
    Dosage: 7 cycles
    Indication: Colorectal Cancer Metastatic
    Start date: 2009-01-28
    End date: 2009-05-13

Fluorouracil

Folinic Acid
    Start date: 2009-05-27
    End date: 2009-09-01

Folinic Acid
    Dosage: 7 cycles
    Indication: Colorectal Cancer Metastatic
    Start date: 2009-01-28
    End date: 2009-05-13

Folinic Acid

Irinotecan Hydrochloride
    Indication: Colorectal Cancer Metastatic
    Start date: 2010-01-01

Oxaliplatin
    Start date: 2008-06-01
    End date: 2008-06-01

Oxaliplatin
    Dosage: 7 cycles

Oxaliplatin

Oxaliplatin

Oxaliplatin
    Start date: 2009-05-13
    End date: 2009-05-13

Oxaliplatin
    Indication: Colorectal Cancer Metastatic

Oxaliplatin
    Start date: 2008-12-18
    End date: 2008-12-18

Oxaliplatin

Oxaliplatin
    Dosage: dose lowered

Oxaliplatin

Xeloda
    Administration route: Oral

Xeloda
    Dosage: two cycles
    Administration route: Oral
    Indication: Colorectal Cancer Metastatic
    Start date: 2008-12-18
    End date: 2009-01-07

Xeloda
    Administration route: Oral

Xeloda
    Dosage: two tablets in morning
    Administration route: Oral

Other drugs received by patient: Dexamethasone; Zofran; Prilosec



Possible Xeloda side effects in female

Reported by a physician from Germany on 2012-07-11

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Mucosal Inflammation, Vomiting, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xeloda



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014